Regulus Therapeutics | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Biogen USD 572.5M 104.8M 2025-03
Celldex Therapeutics USD 10.82M 557K 2025-03
Cipla INR 12.33B 354.8M 2025-03
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.37M 361K 2024-12
CSL USD 1.18B 201M 2024-12
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Grifols EUR 269.48M 49.95M 2024-12
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
Merck USD 2.53B 319M 2025-03
Sanofi EUR 1.24B 1.44B 2024-12
Takeda JPY 295.87B 25.28B 2025-03



Regulus Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.